XML 90 R61.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share-based Compensation Expenses | The share-based compensation expense included in the determination of net earnings (loss) was:
Years ended December 31, |  | 2024 |  |  | 2023 |
Deferred share units |  | $ | 11 |  |  | $ | (1 | )
Performance share units |  |  | 7 |  |  |  | - |
Restricted share units |  |  | 10 |  |  |  | 5 |
Cash performance target |  |  | 1 |  |  |  | 2 |
Share-based compensation expense |  | $ | 29 |  |  | $ | 6 |
Summary of Equity-Settled Share-Based Payments | (b) Equity-Settled Share-Based Payments
|  | 2024 |  |  | 2023 |
Years ended December 31, |  | Number of options |  |  | TSX CAD Weighted average exercise price |  |  | Number of options |  |  | TSX CAD Weighted average exercise price |
Options outstanding, beginning of period |  |  | 2,297,975 |  |  | $ | 11.12 |  |  |  | 3,089,229 |  |  | $ | 10.77 |
Exercised 1 |  |  | (186,314 | ) |  | 5.95 |  |  |  | (217,845 | ) |  |  | 5.87 |
Forfeited |  |  | (118,935 | ) |  | 8.45 |  |  |  | (318,840 | ) |  |  | 9.54 |
Expired |  |  | (466,403 | ) |  | 15.33 |  |  |  | (254,569 | ) |  |  | 13.32 |
Options outstanding, end of period |  |  | 1,526,323 |  |  | $ | 10.67 |  |  |  | 2,297,975 |  |  | $ | 11.12 |
Options exercisable, end of period |  |  | 1,237,006 |  |  | $ | 11.54 |  |  |  | 1,589,639 |  |  | $ | 12.52 |
1 The weighted average share price of options at the date of exercise for the year ended December 31, 2024, was CAD $10.42 (December 31, 2023 – CAD $8.16).
Summary of Options Outstanding and Exercisable | The following table summarizes options outstanding and exercisable at December 31, 2024:
|  | Options Outstanding |  |  | Options Exercisable |
Range of exercise prices 1 |  | Number outstanding |  |  | Weighted average remaining life (years) |  | Weighted average exercise price |  |  | Number outstanding |  |  | Weighted average remaining life (years) |  | Weighted average exercise price |
$5.51 – $6.68 |  |  | 323,237 |  |  | 2.62 |  | $ | 5.51 |  |  |  | 212,730 |  |  | 2.62 |  | $ | 5.51 |
$6.69 – $13.07 |  |  | 519,320 |  |  | 3.32 |  | 8.53 |  |  |  | 340,510 |  |  | 3.17 |  | 8.89 |
$13.08 – $16.12 |  |  | 683,766 |  |  | 1.19 |  | 14.74 |  |  |  | 683,766 |  |  | 1.19 |  | 14.74 |
Total |  |  | 1,526,323 |  |  | 2.22 |  | $ | 10.67 |  |  |  | 1,237,006 |  |  | 1.98 |  | $ | 11.54 |
1 The range of exercise prices equal the weighted average market price of the Company’s shares on the five days preceding the effective date of the grant based on prices from the Toronto Stock Exchange ("TSX").
Deferred share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  |  |  |  | TSX CAD |  |  |  |  |  | NYSE USD |
DSUs outstanding |  | Number of DSUs |  |  | Weighted average grant date fair value per unit |  |  | Number of DSUs |  |  | Weighted average grant date fair value per unit |
December 31, 2023 |  |  | 1,560,110 |  |  | $ | 10.45 |  |  |  | - |  |  | $ | - |
Granted |  |  | 259,563 |  |  | 8.66 |  |  |  | 12,711 |  |  | 6.24 |
In lieu of dividends |  |  | 22,566 |  |  | 7.16 |  |  |  | 122 |  |  | 5.72 |
Vested |  |  | (396,062 | ) |  | 10.01 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (1,220 | ) |  | 5.89 |  |  |  | - |  |  |  | - |
December 31, 2024 |  |  | 1,444,957 |  |  | $ | 10.20 |  |  |  | 12,833 |  |  | $ | 6.24 |
Phantom Share Entitlement Plan [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
PSEs outstanding |  | Number of PSEs |  |  | TSX CAD Weighted average grant date fair value per unit |
December 31, 2023 |  |  | 158,913 |  |  | $ | 12.61 |
Exercised |  |  | (28,770 | ) |  | 6.72 |
Expired |  |  | (27,352 | ) |  | 15.75 |
December 31, 2024 |  |  | 102,791 |  |  | $ | 13.42 |
Performance share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  |  |  |  | TSX CAD |  |  |  |  |  | NYSE USD |
PSUs outstanding |  | Number of PSUs |  |  | Weighted average grant date fair value per unit |  |  | Number of PSUs |  |  | Weighted average grant date fair value per unit |
December 31, 2023 |  |  | 1,210,895 |  |  | $ | 9.40 |  |  |  | 272,729 |  |  | $ | 6.23 |
Granted |  |  | 378,438 |  |  |  | 7.98 |  |  |  | 185,842 |  |  |  | 5.88 |
In lieu of dividends |  |  | 15,996 |  |  |  | 7.18 |  |  |  | 3,641 |  |  |  | 5.34 |
Vested |  |  | (274,113 | ) |  |  | 7.67 |  |  |  | (63,699 | ) |  |  | 5.41 |
Forfeited |  |  | (168,680 | ) |  |  | 7.60 |  |  |  | (46,887 | ) |  |  | 6.24 |
December 31, 2024 |  |  | 1,162,536 |  |  | $ | 9.58 |  |  |  | 351,626 |  |  | $ | 6.18 |
Restricted share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  |  |  |  | TSX CAD |  |  |  |  |  | NYSE USD |
RSUs outstanding |  | Number of RSUs |  |  | Weighted average grant date fair value per unit |  |  | Number of RSUs |  |  | Weighted average grant date fair value per unit |
December 31, 2023 |  |  | 1,773,592 |  |  | $ | 6.79 |  |  |  | 728,591 |  |  | $ | 6.24 |
Granted |  |  | 958,680 |  |  |  | 7.99 |  |  |  | 689,027 |  |  |  | 5.88 |
In lieu of dividends |  |  | 23,403 |  |  |  | 7.19 |  |  |  | 10,664 |  |  |  | 5.38 |
Vested |  |  | (831,454 | ) |  |  | 8.11 |  |  |  | (275,857 | ) |  |  | 5.80 |
Forfeited |  |  | (171,629 | ) |  |  | 7.24 |  |  |  | (122,038 | ) |  |  | 6.14 |
December 31, 2024 |  |  | 1,752,592 |  |  | $ | 6.78 |  |  |  | 1,030,387 |  |  | $ | 6.12 |

X
- Definition Disclosure details of share based compensation expenses explanatory. + References No definition available. + Details
Name: | efxt_DisclosureDetailsOfShareBasedCompensationExpensesExplanatory
Namespace Prefix: | efxt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_DeferredShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_PhantomShareEntitlementPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_PerformanceShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |